Ruth Greferath
Keine laufenden Positionen mehr
Karriereverlauf von Ruth Greferath
Ehemalige bekannte Positionen von Ruth Greferath
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AC IMMUNE SA | Gründer | 13.02.2003 | - |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Gründer | 03.08.2009 | - |
| Corporate Officer/Principal | 31.07.2009 | - |
Ausbildung von Ruth Greferath
| Yeshiva University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Schweiz | 2 |
Operativ
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
- Börse
- Insiders
- Ruth Greferath
- Erfahrung
